{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:24:49Z","timestamp":1790727889642,"version":"4.1.0"},"reference-count":50,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61972007"],"award-info":[{"award-number":["61972007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver condition worldwide. Numerous studies conducted recently have demonstrated a connection between the dysbiosis of the development of NAFLD and gut microbiota. Rebuilding a healthy gut ecology has been proposed as a strategy involving the use of probiotics. The purpose of this work is to investigate and compare the function of probiotics Akkermansia muciniphila (A. muciniphila) and VSL#3 in NAFLD mice. Rodent NAFLD was modeled using a methionine choline-deficient diet (MCD) with\/without oral probiotic delivery. Subsequently, qPCR, histological staining, and liver function tests were conducted. Mass spectrometry-based analysis and 16S rDNA gene sequencing were used to investigate the liver metabolome and gut microbiota. We found that while both A. muciniphila and VSL#3 reduced hepatic fat content, A. muciniphila outperformed VSL#3. Furthermore, probiotic treatment restored the \u03b2 diversity of the gut flora and A. muciniphila decreased the abundance of pathogenic bacteria such as Ileibacterium valens. These probiotics altered the metabolism in MCD mice, especially the glycerophospholipid metabolism. In conclusion, our findings distinguished the role of A. muciniphila and VSL#3 in NAFLD and indicated that oral-gavage probiotics remodel gut microbiota and improve metabolism, raising the possibility of using probiotics in the cure of NAFLD.<\/jats:p>","DOI":"10.3390\/microorganisms12051020","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T03:36:42Z","timestamp":1716176202000},"page":"1020","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of Probiotics in Gut Microbiome and Metabolome in Non-Alcoholic Fatty Liver Disease Mouse Model: A Comparative Study"],"prefix":"10.3390","volume":"12","author":[{"given":"Tian","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4997-4223","authenticated-orcid":false,"given":"Zheng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"ref_1","first-page":"404","article-title":"Epidemiology of nonalcoholic fatty liver disease in Europe: A systematic review and meta-analysis","volume":"34","author":"Cholongitas","year":"2021","journal-title":"Ann. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11739-022-03139-x","article-title":"NAFLD as the metabolic hallmark of obesity","volume":"18","author":"Rojano","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_4","first-page":"42","article-title":"Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"5","author":"Raza","year":"2019","journal-title":"Hepatoma Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fang, J., Yu, C.-H., Li, X.-J., Yao, J.-M., Fang, Z.-Y., Yoon, S.-H., and Yu, W.-Y. (2022). Gut dysbiosis in nonalcoholic fatty liver disease: Pathogenesis, diagnosis, and therapeutic implications. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.997018"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ore, A., and Akinloye, O.A. (2021). Phytotherapy as multi-hit therapy to confront the multiple pathophysiology in non-alcoholic fatty liver disease: A systematic review of experimental interventions. Medicina, 57.","DOI":"10.3390\/medicina57080822"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hoozemans, J., de Brauw, M., Nieuwdorp, M., and Gerdes, V. (2021). Gut microbiome and metabolites in patients with NAFLD and after bariatric surgery: A comprehensive review. Metabolites, 11.","DOI":"10.3390\/metabo11060353"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"154844","DOI":"10.1016\/j.metabol.2021.154844","article-title":"Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease","volume":"123","author":"Nawrot","year":"2021","journal-title":"Metabolism"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"592157","DOI":"10.3389\/fendo.2020.592157","article-title":"Can you trust your gut? Implicating a disrupted intestinal microbiome in the progression of NAFLD\/NASH","volume":"11","author":"Jadhav","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/apt.12758","article-title":"Randomised clinical trial: The beneficial effects of VSL# 3 in obese children with non-alcoholic steatohepatitis","volume":"39","author":"Alisi","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2221485","DOI":"10.1080\/19490976.2023.2221485","article-title":"Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated \u03b3\u03b4T17 cell and macrophage polarization","volume":"15","author":"Han","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.gastro.2020.03.010","article-title":"Lactococcus lactis subspecies cremoris elicits protection against metabolic changes induced by a western-style diet","volume":"159","author":"Naudin","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chong, C.Y.L., Orr, D., Plank, L.D., Vatanen, T., O\u2019Sullivan, J.M., and Murphy, R. (2020). Randomised double-blind placebo-controlled trial of inulin with metronidazole in non-alcoholic fatty liver disease (NAFLD). Nutrients, 12.","DOI":"10.3390\/nu12040937"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/523341","article-title":"Probiotics: Definition, sources, selection, and uses","volume":"46","author":"Sanders","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/00325481.2020.1731214","article-title":"Health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12 in children","volume":"132","author":"Szajewska","year":"2020","journal-title":"Postgrad. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.molmet.2019.08.020","article-title":"Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice","volume":"29","author":"Zhao","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/dom.12861","article-title":"Metabolic effects of L actobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial","volume":"19","author":"Mobini","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1039\/D0FO02939D","article-title":"Exercise training combined with Bifidobacterium longum OLP-01 treatment regulates insulin resistance and physical performance in db\/db mice","volume":"12","author":"Hsu","year":"2021","journal-title":"Food Funct."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Oniszczuk, A., Oniszczuk, T., Gancarz, M., and Szyma\u0144ska, J. (2021). Role of gut microbiota, probiotics and prebiotics in the cardiovascular diseases. Molecules, 26.","DOI":"10.3390\/molecules26041172"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sanchez-Rodriguez, E., Egea-Zorrilla, A., Plaza-D\u00edaz, J., Arag\u00f3n-Vela, J., Mu\u00f1oz-Quezada, S., Tercedor-S\u00e1nchez, L., and Abadia-Molina, F. (2020). The gut microbiota and its implication in the development of atherosclerosis and related cardiovascular diseases. Nutrients, 12.","DOI":"10.3390\/nu12030605"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1099\/ijs.0.02873-0","article-title":"Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium","volume":"54","author":"Derrien","year":"2004","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41564-021-00880-5","article-title":"Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice","volume":"6","author":"Yoon","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1927633","DOI":"10.1080\/19490976.2021.1927633","article-title":"Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis","volume":"13","author":"Rao","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ashrafian, F., Shahriary, A., Behrouzi, A., Moradi, H.R., Keshavarz Azizi Raftar, S., Lari, A., Hadifar, S., Yaghoubfar, R., Ahmadi Badi, S., and Khatami, S. (2019). Akkermansia muciniphila-derived extracellular vesicles as a mucosal delivery vector for amelioration of obesity in mice. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02155"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e03004","DOI":"10.1128\/AEM.03004-19","article-title":"Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis","volume":"86","author":"Kim","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","article-title":"Akkermansia muciniphila: Paradigm for next-generation beneficial microorganisms","volume":"19","author":"Cani","year":"2022","journal-title":"Nat. Rev. Gastro. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"G34","DOI":"10.1152\/ajpgi.00298.2016","article-title":"Probiotic mixture VSL# 3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice","volume":"312","author":"Kumar","year":"2017","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/ijpo.12273","article-title":"Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: A 16-week, randomized, placebo-controlled trial","volume":"13","author":"Jones","year":"2018","journal-title":"Pediatr. Obes."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.22711","article-title":"VSL# 3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice","volume":"49","author":"Velayudham","year":"2009","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.21037\/hbsn.2019.09.07","article-title":"Probiotics VSL# 3 are effective in reversing non-alcoholic steatohepatitis in a mouse model","volume":"9","author":"Jena","year":"2020","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41430-020-0607-6","article-title":"Profile of the gut microbiota of adults with obesity: A systematic review","volume":"74","author":"Crovesy","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jad.2016.09.051","article-title":"Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder","volume":"207","author":"Lin","year":"2017","journal-title":"J. Affect. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/hep.29892","article-title":"Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1099\/ijsem.0.001793","article-title":"Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibacterium rodentium","volume":"67","author":"Cox","year":"2017","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","article-title":"Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer","volume":"25","author":"Yachida","year":"2019","journal-title":"Nat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"112997","DOI":"10.1016\/j.celrep.2023.112997","article-title":"Paired microbiome and metabolome analyses associate bile acid changes with colorectal cancer progression","volume":"42","author":"Fu","year":"2023","journal-title":"Cell Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e14051","DOI":"10.1111\/acel.14051","article-title":"Long term methionine restriction: Influence on gut microbiome and metabolic characteristics","volume":"23","author":"Nagarajan","year":"2024","journal-title":"Aging Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e00692-13","DOI":"10.1128\/mBio.00692-13","article-title":"The gut microbiome modulates colon tumorigenesis","volume":"4","author":"Zackular","year":"2013","journal-title":"mBio"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1038\/s41598-018-25190-5","article-title":"Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice","volume":"8","author":"Ma","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Bian, X., Wu, W., Yang, L., Lv, L., Wang, Q., Li, Y., Ye, J., Fang, D., Wu, J., and Jiang, X. (2019). Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02259"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/03014460.2016.1267261","article-title":"Microbiome, growth retardation and metabolism: Are they related?","volume":"44","author":"Hoffman","year":"2017","journal-title":"Ann. Hum. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1021\/acs.accounts.2c00510","article-title":"Imaging and editing the phospholipidome","volume":"55","author":"Chiu","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","article-title":"The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis","volume":"3","author":"Li","year":"2006","journal-title":"Cell Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"100973","DOI":"10.1016\/j.mam.2021.100973","article-title":"Autophagy in liver diseases: A review","volume":"82","author":"Qian","year":"2021","journal-title":"Mol. Asp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.3340856","article-title":"Glycosyl-phosphatidylinositol moiety that anchors Trypanosoma brucei variant surface glycoprotein to the membrane","volume":"239","author":"Ferguson","year":"1988","journal-title":"Science"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/5\/1020\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:44:21Z","timestamp":1760107461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/5\/1020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["microorganisms12051020"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms12051020","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]}}}